G01N 2800/56
Staging of a disease
Official title: Staging of a disease; Further complications associated with the disease
G01N2800/56 (Staging of a disease) appears on 741 US grants and 1,899 published applications in this corpus.
Search patents in G01N- Granted patents
- 741
- Published applications
- 1,899
- Assignees
- 961
- Inventors
- 3,714
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 4 |
| 2006 | 1 | 3 |
| 2007 | 0 | 5 |
| 2008 | 3 | 17 |
| 2009 | 1 | 42 |
| 2010 | 5 | 69 |
| 2011 | 16 | 122 |
| 2012 | 17 | 124 |
| 2013 | 41 | 128 |
| 2014 | 44 | 120 |
| 2015 | 45 | 121 |
| 2016 | 53 | 139 |
| 2017 | 54 | 108 |
| 2018 | 60 | 139 |
| 2019 | 58 | 119 |
| 2020 | 66 | 114 |
| 2021 | 77 | 97 |
| 2022 | 44 | 93 |
| 2023 | 35 | 117 |
| 2024 | 46 | 86 |
| 2025 | 42 | 64 |
| 2026 | 32 | 65 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for the detection and treatment of ovarian cancer22 Sep 2026US 12,742,780 B2Board of Regents, The University of Texas System
- Cancer diagnosis using Ki-674 Aug 2026US 12,699,095 B2Quest Diagnostics Investments Incorporated
- Diagnosis of stage B2 DMVD21 Jul 2026US 12,687,550 B2Boehringer Ingelheim Vetmedica GmbH
- Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (SARS)14 Jul 2026US 12,681,017 B2
- Methods and kits for predicting infusion reaction risk and antibody mediated loss of response by monitoring serum uric acid during pegylated uricase therapy30 Jun 2026US 12,669,498 B2Horizon Therapeutics USA, Inc.
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Methods and compositions for diagnosing brain injury or neurodegeneration8 Oct 2026US 2026/0309724 A1Brainbox Solutions, Inc.
- Methods for differentiating benign prostatic hyperplasia from prostate cancer24 Sep 2026US 2026/0287590 A1BPGbio, Inc.
- Methods of treating alzheimer's disease17 Sep 2026US 2026/0274931 A1Klaritos, Inc.
- Non-invasive assay for detecting and monitoring systemic inflammation17 Sep 2026US 2026/0276654 A1Ichilov Tech Ltd.
Most cited
By later US patents
- PODXL protein in colorectal cancer143US 8,999,656 B2Atlas Antibodies AB · 2015
- Marker associated with non-alcoholic steatohepatitis95US 9,060,981 B2Mochida Pharmaceutical Co., Ltd. · 2015
- Method for determining insulin sensitivity with biomarkers68US 8,187,830 B2Metabolon, Inc. · 2012
- System and method for diagnosis and treatment44US 9,314,473 B2Pop Test Oncology Limited Liability Company · 2016
- Predicting mortality and detecting severe disease43US 7,998,683 B2Critical Care Diagnostics, Inc. · 2011